Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipid Metabolism | 14 | 2023 | 109 | 3.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 13 | 2023 | 592 | 3.420 |
Why?
|
| Insulin Resistance | 15 | 2020 | 177 | 3.200 |
Why?
|
| Muscle, Skeletal | 16 | 2023 | 257 | 2.910 |
Why?
|
| Mitochondria, Muscle | 8 | 2017 | 16 | 2.480 |
Why?
|
| Exercise | 11 | 2022 | 524 | 2.410 |
Why?
|
| Muscle Fibers, Skeletal | 11 | 2018 | 60 | 2.360 |
Why?
|
| Electric Stimulation Therapy | 1 | 2023 | 11 | 0.950 |
Why?
|
| Resistance Training | 1 | 2022 | 17 | 0.840 |
Why?
|
| Hyperglycemia | 1 | 2022 | 53 | 0.820 |
Why?
|
| Young Adult | 17 | 2023 | 4012 | 0.760 |
Why?
|
| Adult | 25 | 2023 | 11034 | 0.750 |
Why?
|
| Obesity | 10 | 2023 | 965 | 0.740 |
Why?
|
| Medical History Taking | 1 | 2020 | 33 | 0.740 |
Why?
|
| Quadriceps Muscle | 3 | 2016 | 5 | 0.720 |
Why?
|
| Motor Activity | 4 | 2015 | 393 | 0.670 |
Why?
|
| Physical Fitness | 3 | 2020 | 78 | 0.630 |
Why?
|
| Nucleosomes | 1 | 2017 | 27 | 0.620 |
Why?
|
| Vesicular Transport Proteins | 2 | 2014 | 40 | 0.610 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 465 | 0.600 |
Why?
|
| Male | 23 | 2023 | 18870 | 0.590 |
Why?
|
| Adipose Tissue | 6 | 2017 | 167 | 0.590 |
Why?
|
| MicroRNAs | 1 | 2022 | 386 | 0.590 |
Why?
|
| Humans | 33 | 2023 | 34853 | 0.580 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 48 | 0.570 |
Why?
|
| Sirtuins | 1 | 2015 | 12 | 0.560 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 65 | 0.540 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 152 | 0.530 |
Why?
|
| Coatomer Protein | 1 | 2014 | 2 | 0.500 |
Why?
|
| Oxygen Consumption | 5 | 2018 | 98 | 0.500 |
Why?
|
| Phosphoproteins | 1 | 2015 | 154 | 0.490 |
Why?
|
| DNA Methylation | 1 | 2017 | 301 | 0.490 |
Why?
|
| Carrier Proteins | 1 | 2015 | 287 | 0.460 |
Why?
|
| Glucose Clamp Technique | 4 | 2020 | 7 | 0.400 |
Why?
|
| Cells, Cultured | 7 | 2017 | 1442 | 0.380 |
Why?
|
| Muscle Fibers, Slow-Twitch | 3 | 2015 | 7 | 0.370 |
Why?
|
| Body Composition | 4 | 2020 | 146 | 0.360 |
Why?
|
| Middle Aged | 8 | 2023 | 9642 | 0.320 |
Why?
|
| Physical Endurance | 3 | 2014 | 18 | 0.310 |
Why?
|
| Lipids | 2 | 2023 | 222 | 0.300 |
Why?
|
| Energy Metabolism | 5 | 2017 | 160 | 0.280 |
Why?
|
| Body Mass Index | 5 | 2013 | 775 | 0.280 |
Why?
|
| Blood Glucose | 2 | 2022 | 333 | 0.270 |
Why?
|
| Choristoma | 2 | 2017 | 4 | 0.260 |
Why?
|
| Oxidative Phosphorylation | 2 | 2015 | 49 | 0.250 |
Why?
|
| Insulin | 5 | 2017 | 224 | 0.250 |
Why?
|
| Glycogen | 3 | 2018 | 17 | 0.240 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2023 | 12 | 0.240 |
Why?
|
| Electric Stimulation | 1 | 2023 | 177 | 0.230 |
Why?
|
| Health Services | 1 | 2023 | 53 | 0.230 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 4 | 0.230 |
Why?
|
| Female | 12 | 2017 | 19873 | 0.230 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 19 | 0.230 |
Why?
|
| Triglycerides | 3 | 2013 | 129 | 0.210 |
Why?
|
| Diglycerides | 2 | 2013 | 10 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2023 | 1152 | 0.200 |
Why?
|
| Exercise Therapy | 2 | 2020 | 64 | 0.200 |
Why?
|
| Cross-Sectional Studies | 6 | 2015 | 2561 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 209 | 0.200 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 220 | 0.190 |
Why?
|
| Biopsy | 3 | 2017 | 151 | 0.190 |
Why?
|
| Adenosine Triphosphate | 3 | 2016 | 180 | 0.180 |
Why?
|
| Prognosis | 1 | 2022 | 707 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 968 | 0.180 |
Why?
|
| Oxidation-Reduction | 4 | 2014 | 407 | 0.170 |
Why?
|
| Palmitic Acid | 2 | 2018 | 24 | 0.170 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 121 | 0.170 |
Why?
|
| Liver | 3 | 2016 | 447 | 0.170 |
Why?
|
| Ceramides | 3 | 2013 | 41 | 0.160 |
Why?
|
| Mexican Americans | 1 | 2020 | 177 | 0.160 |
Why?
|
| Aged | 3 | 2023 | 6448 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 859 | 0.150 |
Why?
|
| Lipolysis | 2 | 2014 | 18 | 0.150 |
Why?
|
| Fatty Acids | 3 | 2012 | 118 | 0.140 |
Why?
|
| Weight Gain | 2 | 2014 | 128 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2016 | 269 | 0.140 |
Why?
|
| ADP Ribose Transferases | 1 | 2015 | 5 | 0.140 |
Why?
|
| Adiposity | 3 | 2014 | 145 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2015 | 29 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 32 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 78 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 198 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 484 | 0.130 |
Why?
|
| Overnutrition | 1 | 2014 | 5 | 0.130 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2014 | 26 | 0.130 |
Why?
|
| Epinephrine | 1 | 2014 | 35 | 0.120 |
Why?
|
| Longevity | 1 | 2015 | 143 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 17 | 0.120 |
Why?
|
| Adolescent | 3 | 2020 | 5035 | 0.120 |
Why?
|
| Glucose | 2 | 2012 | 217 | 0.120 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2013 | 8 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 111 | 0.120 |
Why?
|
| Phenotype | 1 | 2015 | 650 | 0.110 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2012 | 12 | 0.110 |
Why?
|
| Glucose Tolerance Test | 2 | 2012 | 66 | 0.110 |
Why?
|
| Energy Intake | 1 | 2013 | 160 | 0.110 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2012 | 4 | 0.110 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2012 | 2 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 60 | 0.110 |
Why?
|
| Physical Exertion | 1 | 2012 | 25 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 2011 | 20 | 0.100 |
Why?
|
| Citrate (si)-Synthase | 1 | 2011 | 12 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 42 | 0.100 |
Why?
|
| Adenoviridae Infections | 1 | 2011 | 4 | 0.100 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 8 | 0.100 |
Why?
|
| Body Weight | 2 | 2013 | 404 | 0.100 |
Why?
|
| Thermogenesis | 1 | 2011 | 20 | 0.100 |
Why?
|
| Exercise Test | 1 | 2011 | 68 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 72 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2011 | 115 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 96 | 0.090 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 7 | 0.090 |
Why?
|
| Lipase | 1 | 2009 | 16 | 0.090 |
Why?
|
| Anaerobic Threshold | 1 | 2009 | 4 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2009 | 42 | 0.080 |
Why?
|
| Calcium | 1 | 2011 | 445 | 0.080 |
Why?
|
| Homeostasis | 1 | 2009 | 172 | 0.080 |
Why?
|
| Diet | 1 | 2013 | 747 | 0.080 |
Why?
|
| Cytokines | 1 | 2009 | 569 | 0.070 |
Why?
|
| Mice | 4 | 2022 | 5668 | 0.060 |
Why?
|
| Ionomycin | 2 | 2016 | 9 | 0.060 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2017 | 39 | 0.060 |
Why?
|
| Mitochondria | 3 | 2012 | 454 | 0.060 |
Why?
|
| Genes, Switch | 1 | 2022 | 3 | 0.060 |
Why?
|
| Animals | 6 | 2022 | 14307 | 0.060 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 9 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 117 | 0.050 |
Why?
|
| Disease Progression | 1 | 2022 | 580 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2012 | 897 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 63 | 0.040 |
Why?
|
| Palmitates | 1 | 2016 | 13 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 18 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2016 | 59 | 0.030 |
Why?
|
| Myostatin | 1 | 2016 | 57 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2016 | 87 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 140 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2014 | 21 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 148 | 0.030 |
Why?
|
| Adipocytes | 1 | 2014 | 54 | 0.030 |
Why?
|
| Dietetics | 1 | 2013 | 23 | 0.030 |
Why?
|
| Rest | 1 | 2012 | 25 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2012 | 33 | 0.030 |
Why?
|
| Electron Transport | 1 | 2012 | 38 | 0.030 |
Why?
|
| Acetyl Coenzyme A | 1 | 2012 | 7 | 0.030 |
Why?
|
| Carnitine | 1 | 2012 | 8 | 0.030 |
Why?
|
| Acetylcarnitine | 1 | 2012 | 8 | 0.030 |
Why?
|
| Eating | 1 | 2013 | 152 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 115 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 628 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 73 | 0.030 |
Why?
|
| Carbon | 1 | 2012 | 95 | 0.030 |
Why?
|
| Fasting | 1 | 2011 | 50 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2011 | 59 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 18 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 26 | 0.020 |
Why?
|
| Ion Channels | 1 | 2011 | 69 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 164 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 210 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1353 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1349 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 152 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2011 | 56 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 490 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 562 | 0.020 |
Why?
|
| Myoblasts | 1 | 2009 | 25 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 496 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 51 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 252 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 605 | 0.020 |
Why?
|
| Sports | 1 | 2009 | 47 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 834 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 288 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2007 | 61 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1681 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 1530 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 859 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 2333 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 1961 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2009 | 653 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 1802 | 0.010 |
Why?
|